DEBATE: "Energy Drinks Should Be Banned for Those Under 18"

DEBATE STRUCTURE OVERVIEW

OPENING SPEECH (1st Proposition Speaker)

"Honourable judges, respected opponents, and my fellow MBBS colleagues - as future clinicians, we are taught first, do no harm. Today I stand before you to argue that selling energy drinks to those under 18 is, by the very evidence we study in our pharmacology and physiology classes, doing harm - every single can sold."

FRAMEWORK (Define the debate)

ARGUMENT 1 - CARDIOVASCULAR TOXICITY IN THE DEVELOPING HEART

• A 2021 peer-reviewed review in Pediatric Emergency Care (Moussa et al., PMID 32569249) documented that energy drink consumption in the pediatric population causes: short-term hypertension, tachycardia, decreased cerebral blood flow, unmasking of latent channelopathies (Long QT syndrome, Brugada syndrome), and frank ventricular fibrillation. These are not theoretical risks - these are documented emergency department presentations.
• Taurine, present at 1,000-2,000 mg per can, modulates intracellular calcium handling. In an immature myocyte, this disrupts normal SR calcium cycling and can potentiate arrhythmias.
• Drug interactions are especially relevant for the paediatric population: caffeine is a potent CYP1A2 inhibitor, meaning adolescents on common medications (SSRIs, antipsychotics, antiepileptics) can develop unpredictable drug toxicity when they consume energy drinks. As future prescribers, you will see this.

Point to land: A single can of Monster contains 160 mg caffeine. The EFSA (European Food Safety Authority) safe daily caffeine threshold for adolescents is 3 mg/kg/day - meaning for a 50 kg teenager, that is 150 mg/day total. One can exceeds this entirely. There is zero therapeutic benefit, only dose-dependent cardiovascular risk.

ARGUMENT 2 - NEURODEVELOPMENTAL HARM

• A systematic review published in the Journal of Psychosocial Nursing and Mental Health Services (Silva-Maldonado et al., 2022, PMID 34432594) reviewed studies on adolescents aged 11-18 and found strong, consistent associations between energy drink consumption and:
  • Anxiety and depression
  • Impulsivity and risk-taking behaviour
  • Poor academic performance
  • Significant sleep disturbances (reduced duration and quality)
  • A 25-75% progressive increase in consumption was noted within 5 years of tracking.
• The mechanism is clear from our neurophysiology: caffeine blocks adenosine A1 and A2A receptors in the nucleus accumbens and prefrontal cortex, disrupting normal GABAergic and dopaminergic tone during a critical developmental window. This is particularly relevant to addiction vulnerability - the adolescent mesolimbic system is more sensitive to reward-pathway dysregulation than the adult brain.
• Sleep disruption is a separate, compounding harm. Sleep in adolescence is when growth hormone is secreted (GH pulse during slow-wave sleep), synaptic pruning occurs, and memory consolidation takes place. Disrupting this with a nightly energy drink is not a trivial lifestyle choice - it is a physiological insult to neurodevelopment.

ARGUMENT 3 - SCALE: THEY ARE THE PRIMARY CONSUMER GROUP

• A 2025 systematic review in Public Health Nutrition (Teijeiro et al., PMID 40457699) reviewed 94 European studies and confirmed that school-aged children are the most studied and most prevalent consumption group, with consumption rates rising when tracked over time.
• The UK Government's 2025 consultation on banning energy drink sales to children cited a systematic review of 57 studies covering over 1.2 million children and young people across 21 countries (Ajibo et al., 2024). Findings: increased headaches, tiredness, stomach aches, reduced sleep quality, increased risk of suicide ideation, and reduced academic performance - all dose-dependently linked to energy drink consumption.
• In Poland alone (population 38 million), over 50% of adolescents regularly consumed energy drinks before the 2024 ban - leading directly to legislative intervention (Holt, The Lancet, 2023, PMID referenced in Mularczyk-Tomczewska et al., 2025, PMC11960718).

Point to land: When over half of a country's adolescents are consuming a substance that exceeds safe caffeine thresholds, we have crossed from individual risk into a public health emergency.

ARGUMENT 4 - GLOBAL MEDICAL AND REGULATORY CONSENSUS

• Lithuania - ban since 2014 (under 18)
• Latvia - ban since 2016 (under 18)
• Turkey, Sweden - under-18 bans enacted
• Poland, Estonia - ban since January 2024
• Hungary, Bulgaria - ban enacted June and November 2025
• Honduras - first Latin American country to implement under-18 ban (2024)
• Kazakhstan - WHO Europe praised the ban implemented in early 2025
• UK - actively consulting on under-16 ban as of September 2025 (UK Government consultation)

Medical consensus supports bans. The regulatory trend globally supports bans. Our own pharmacology supports bans. The question is not whether the evidence exists - it does. The question is whether we act on it.

SECOND PROPOSITION SPEECH (Rebuttals)

ANTICIPATED OPPOSITION ARGUMENTS AND HOW TO DESTROY THEM

Rebuttal: Rights discourse assumes informed, autonomous agents. Adolescent neuroscience tells us the prefrontal cortex - the seat of consequential decision-making - is developmentally incomplete until age 25. We do not allow under-18s to buy alcohol, tobacco, or prescription stimulants on the grounds of freedom. If anything, MBBS training teaches us that truly protecting autonomy means protecting a developing brain from chemical influence until it can make fully informed decisions. Freedom is not freedom if it is undermined by a beverage engineered to cause dopamine dysregulation.

Rebuttal: This is the weakest possible argument against any public health legislation. We do not abandon seat belt laws because some people don't buckle up. We do not stop prescribing medications because compliance is imperfect. The Polish 2025 study showed early enforcement gaps, but even partial enforcement shifts social norms, empowers retailers to refuse sales, and - critically - supports public health education campaigns. The law creates the framework. Enforcement follows with time and political will.

Rebuttal: This argument attempts to hold epidemiology to an impossible standard. We cannot run a randomised controlled trial giving adolescents high-dose caffeine daily for two years - that would be deeply unethical. But the Bradford Hill criteria for causation do not require an RCT. We have: biological plausibility (caffeine mechanism at adenosine receptors is well characterised), dose-response relationship (more drinks = worse outcomes), temporal consistency (consumption precedes outcomes), coherence with animal data, and consistency across 57 studies in 21 countries. This is the same quality of evidence on which we banned leaded petrol and advised against smoking. The science is sufficient.

Rebuttal: Precisely because biology differentiates them. An adult's hepatic CYP1A2 expression, BBB integrity, cardiac conduction maturity, and adrenal axis regulation are all substantially more robust than an adolescent's. Pharmacology is dose and physiology - and adolescent physiology is fundamentally different. This is not a social opinion. It is basic pharmacokinetics.

Rebuttal: We are not debating sugar. Energy drinks are a distinct product category containing pharmacological doses of caffeine - a psychoactive stimulant with known dose-dependent cardiac, neurological, and psychiatric toxicity. A bag of crisps does not cause ventricular fibrillation. A single energy drink can unmask a channelopathy. The comparison is medically illiterate.

SUMMARY SPEECH (Closing - Proposition)

"Honourable judges - today we have presented you not an opinion, but a clinical case.

The patient is every adolescent who walks into a corner shop and buys a 500 mL can of high-caffeine energy drink. The pathophysiology is clear: caffeine exceeds safe thresholds for their body weight, disrupts a developing cardiac conduction system, dysregulates neurotransmitter balance in a prefrontal cortex still undergoing myelination, fragments sleep, and amplifies risk-taking behaviour.

The epidemiology is undeniable: 57 studies, 1.2 million children, 21 countries - all pointing in the same direction.

The global response is decisive: 15+ countries have enacted bans. WHO Europe endorses restriction. EFSA has published safe limits that current products routinely exceed.

Our opponents told you this was a matter of freedom, of imperfect enforcement, of uncertain causality. We showed you that none of these hold up under clinical or epidemiological scrutiny.

As MBBS students - as future doctors - we take an oath not merely to treat disease but to prevent it. A ban on the sale of energy drinks to those under 18 is not paternalism. It is preventive medicine. It is what the evidence demands.

We urge you to support the motion."

QUICK REFERENCE: KEY FACTS AND CITATIONS

TIPS FOR DELIVERY (MBBS DEBATERS)

1. Use the pharmacology confidently. Saying "adenosine receptor antagonism increases cAMP and catecholamine release" signals clinical competence and is hard for non-medical opponents to challenge.
2. Personalise the stakes. "As future emergency physicians, we will see these patients." It shifts the debate from abstract policy to professional responsibility.
3. Attack the word 'ban' pre-emptively. Frame it as an age restriction - same as alcohol, same as tobacco, same as prescription drugs. The word "ban" sounds extreme; "age restriction" sounds rational.
4. Use exact numbers. "One 500 mL can of Monster = 160 mg caffeine. EFSA limit for a 50 kg teen = 150 mg/day total. One can. Done." Numbers win debates.
5. Bradford Hill criteria - have them ready. If opposition says "no causal proof," name the 9 criteria and demonstrate how EDs meet at least 7 of them.
6. Don't debate sugar in detail. If opposition goes there, pivot: "We are not here about sugar. We are here about pharmacological doses of a central nervous system stimulant."